Categories: CancerHealthcareNews

4baseCare Secures CAP Accreditation, Elevating Genomic Profiling Standards for Cancer Patients in the UAE

FacebookFacebookTwitterTwitterEmailEmailLinkedInLinkedInWhatsAppWhatsAppMessengerMessengerFlipboardFlipboardGmailGmailTelegramTelegramShareShare

BENGALURU, India , March 17, 2025 /PRNewswire/ — 4baseCare, a leader in precision oncology, has achieved a major milestone with CAP (College of American Pathologists) accreditation for its genomics lab at Dubai Science Park, established in partnership with Innovate Life Sciences Fz-LLC. This accreditation ensures that cancer patients in the UAE now have access to world-class genomic profiling locally, meeting the highest international standards of quality and accuracy.

By securing CAP accreditation, 4baseCare reaffirms its commitment to advancing cancer care through data-driven, personalized treatment decisions. The Dubai-based facility bridges a critical gap in precision oncology, eliminating the need for patients to seek genomic testing solutions outside of the UAE .

“Our mission is to democratize access to high-quality genomic insights, empowering oncologists with cutting-edge molecular data to drive better patient outcomes,” said Dr. Sudharshan Elangovan, VP of Global Operations, 4baseCare.

Syed Hussaini, General Manager, Innovate Life Sciences, added, “This achievement underscores our dedication to quality and innovation, strengthening our mission to make precision medicine more accessible and affordable across the Middle East and beyond.”

About 4baseCare

An Illumina Accelerator company backed by Infosys Innovation Fund, 4baseCare pioneers precision oncology solutions through advanced genomics and digital health technology. 4baseCare boasts of a stellar advisory board which includes Lip Bu Tan (CEO, Intel Corporation), Francis deSouza (COO, Google Cloud and ex-CEO Illumina) and Prof George Church (Professor, Harvard Medical School).

With CAP accreditation, the company further cements its position as a trusted global partner in precision oncology, supporting healthcare providers in delivering targeted and effective cancer treatments.

Linkedin page: 4baseCare

Video: https://mma.prnewswire.com/media/2642650/4baseCare_Secures_CAP_Accreditation.mp4

 

View original content to download multimedia:https://www.prnewswire.com/news-releases/4basecare-secures-cap-accreditation-elevating-genomic-profiling-standards-for-cancer-patients-in-the-uae-302402841.html

SOURCE 4baseCare

Staff

Recent Posts

As Pilgrims Arrive in Makkah, Saudi Arabia Rolls Out Massive Operation to Safeguard Health

Massive health operation for world's largest religious gathering with 111,400 health services already delivered. 111,400…

2 hours ago

Mark A. Davis, MD, MS Joins X Boson Inc. Board to Drive Strategy, Innovation, and Healthcare System Integration in AI-Powered Medication Management

Healthcare executive and physician brings decades of healthcare leadership, growth, and operational success to scale…

2 hours ago

Leaders from Sharp HealthCare and MCG Discuss AI-Driven Utilization Management Success at CMSA 2025

Care management experts will discuss the benefits of leveraging new technologies to reduce hospital administrative…

2 hours ago

CaringBridge and DoorDash Partner for Two-Day Fundraising Match to Support Family Caregivers

BLOOMINGTON, Minn. and SAN FRANCISCO, June 5, 2025 /PRNewswire/ -- CaringBridge, the nonprofit health communication platform,…

2 hours ago

HealthVerity and Medeloop Announce Strategic Partnership to Enhance Real-World Evidence Insights with AI-Driven Analytics

PHILADELPHIA and MENLO PARK, Calif., June 5, 2025 /PRNewswire/ -- HealthVerity, the leader in real-world…

2 hours ago